CATS Consultants GmbH
1 products tracked · names used in filings: CATS Consultants GmbH
Upcoming milestones
No upcoming milestones listed.
Recent milestones
Fri 30 Oct 2026🇪🇺 Application withdrawn (EU)
Qezzaqar (catequentinib): EU application withdrawn
Thu 23 Jul 2026🇪🇺 CHMP negative opinion
Qezzaqar (catequentinib): CHMP negative opinion
CATS Consultants GmbH; Orphan · source
Products
| Product | Status | Approved | |
|---|---|---|---|
| 🇪🇺 | Qezzaqar catequentinib | Application withdrawn |
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.